Emergent BioSolutions Inc... (EBS)
NYSE: EBS
· Real-Time Price · USD
4.91
-0.43 (-8.05%)
At close: May 01, 2025, 3:59 PM
Emergent BioSolutions Revenue
Emergent BioSolutions reported an annual revenue of $1.01B, reflecting a -3.4% growth. For the quarter ending December 31, 2024, Emergent BioSolutions generated $189.3M in revenue.
Revenue (ttm)
$1.01B
Revenue Growth
-3.4%
Price / Sales Ratio
0.5
Revenue / Employee
$1.13M
Employees
900
Market Cap
266.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 1.01B | -3.40% |
| Dec 31, 2023 | 1.05B | -6.39% |
| Dec 31, 2022 | 1.12B | -37.47% |
| Dec 31, 2021 | 1.79B | +15.26% |
| Dec 31, 2020 | 1.56B | n/a |